/PRNewswire/ -- Transposon Therapeutics, a biotechnology company focused on developing novel, orally administered therapies for the treatment of...

Curious about how genetics play a role in ALS when there is no family history? Join us on Tuesday, May 27th at 5pm EST for a free one-hour webinar led by Ms ...

/PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives...

A laureate professor working on early diagnosis of ALS, or Amyotrophic Lateral Sclerosis, is one of several Harvard University researchers who have received stop-work orders after the Trump administra...

Join the D-backs in raising awareness and supporting those affected by Amyotrophic Lateral Sclerosis (ALS) on Lou Gehrig Night at Chase Field

ALS MyMatch is the newest initiative from the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital.

/PRNewswire/ -- NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN), a leading clinical-stage biotechnology company focused on developing treatments for severe...

Learn more about how MLB supports the fight against ALS.

The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 participants.

Funded by the NIH, the Access for ALL in ALS Consortium, is a community of 2 coordination centers and 35 research sites across the U.S.

With majestic anthems like “Killing Me Softly” and “The First Time Ever I Saw Your Face,” Ms. Flack, a former schoolteacher, became one of the most widely heard artists of the 1970s.

In 2016, the secret shopper project showed some customer service gaps that could be holding back clinical trial enrollment in ALS. Are thing...

On Thursday, February 6th at 7pm EST, Dr. Lyle Ostrow, Associate Professor of Neurology at the Lewis Katz School of Medicine at Temple University will join ...

This Viewpoint advocates for the expansion of clinical research in amyotrophic lateral sclerosis through the development of a well-organized network of centers and community-based clinics.

Over the course of the last three years, Brooke Eby — known as "Limpbroozkit" on social media — has documented the progression of her ALS for an audience of over 300,000 followers between TikTok and I...

Medicare home health coverage offers the promise of allowing eligible individuals (legally homebound and in need of skilled care), to remain at home with the care they need. According to Medicare law,...

Think about the last time you walked up a staircase. Did you hold the banister? These may seem like arbitrary questions, but for Chris Spaulding, they became central to a legal battle that would consu...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

After being diagnosed with A.L.S. in 2022, Brooke Eby could have turned inward. Instead, she opened up — and found a fan base online.

CDER’s ARC Program | Center for Drug Evaluation and Research

insitro, a machine learning-enabled drug discovery and development company, today announced it has received $25 million from Bristol Myers Squibb (NYS

Corestem Chemon’s stock price hit its daily lower limit as soon as the market opened on Wednesday, following the company's announcement that its phase 3 clinical trial for Neuronata-R, a stem cell the...

Insurers deny tens of millions of claims every year. ProPublica is investigating why claims are denied, what the consequences are for patients and how the appeal process really works.

Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance coverage of a drug that helps.